14
Views
3
CrossRef citations to date
0
Altmetric
Articles

Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease

, , , , , & show all
Pages 135-141 | Received 30 Mar 2005, Accepted 01 Dec 2006, Published online: 23 May 2017

References

  • Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115–26.
  • de Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentra-tion in myocardial ischemia and infarction. Br Heart J1982; 47: 239-43.
  • Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997; 349: 462–6.
  • Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reac-tive protein and serum amyloid A in severe unstable angina. N Engl J Med 1994; 331: 417–24.
  • Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of car-diovascular disease in apparently healthy men. N Engl J Med 1996; 336: 973–9.
  • Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the predic-tion of cardiovascular disease in women. N Engl J Med 2000; 342: 836–43.
  • Tommasi S, Carluccio E, Bentivoglio M, Buccolieri M, Mariotti M, Politano M, Corea L. C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol 1999; 83: 1595–9.
  • Horne BD, Muhlestein JB, Carlquist JF, Bair TL, Madsen TE, Hart NI, Anderson JL. Statin therapy, lipid levels, C-reactive protein and the survival of patients with angio-graphically severe coronary artery disease. J Am Coll Card 2000; 36: 1774–80.
  • Pietila K, Hermens WT, Harmoinen A, Baardman T, Paster-nack A, Topol EJ, Simoons ML. Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase lev-els in patients with acute myocardial infarction treated with alteplase and streptokinase. Am J Cardiol 1997; 80: 1075–7.
  • Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515–8.
  • al-Nawas B, Shah PM. Procalcitonin in patients with and without immunosupression and sepsis. Infection 1996; 24: 434–6.
  • Bernard L, Ferriere F, Casassus P, Malas F, Leveque S, Guillevin L, Lortholary 0. Procalcitonin as an early marker of bacterial infection in severely netreupenic febrile adults. Clin Infect Dis 1998; 27: 914–5.
  • Schwenger V, Sis J, Breitbard A, Andrassy K. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection 1998; 24: 274–6.
  • Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001; 38: 483–93.
  • Braunwald E, Antman EM, Beasley JW, Calif RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer 54V, Smith EE, Steward DE, Theroux P. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommen-dations. A report of the American College of Cardiol-ogy/American Heart Association Task Force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000; 102: 1193–209.
  • Ryan TJ, Antman EM, Brooks NH, Calif RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel B, Russell RO, Smith EE, Weaver WD, Gibbons RJ, Alpert JS, Eagle KA, Gardner TJ, Garson AJ, Gregoratos G. 1999 update: ACC/AHA guide-lines for the management of patients with acute myocardial infarction. A report of the American College of Cardiol-ogy/American Heart Association Task Force on practice guidelines (committee on management of acute myocardial infarction). J Am Coll Cardiol 1999; 34: 890–911.
  • Chockalingam A, Venkatesan S, Dorairajan S, Moorthy C, Chockalingam V, Subramaniam T. Estimation of subjective stress in acute myocardial infarction. J Postgrad Med 2003; 49: 207–210.
  • Gensini GG. A more meaningful scoring system for deter-mining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.
  • Ambrose JA, Winters SL, Arora RR, Eng A, Riccio A, Gorlin R, Fuster V. Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol 1986; 7: 472–8.
  • Ambrose JA, Winters SL, Arora RR, Haft JI, Goldstein R, Rentrop KP, Gorlin R, Fuster V. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol 1985; 6: 1233–8.
  • Pannitteri G, Marino B, Campa PP, Martucci R, Testa U, Peschle C. Interleukins 6 and 8 as mediators of acute phase response in acute myocardial infarction. Am J Cardiol 1997; 80: 623–5.
  • Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Red-wood SR. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 2002; 39: 1917–23.
  • Tomoda H, Aoki N. Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction. Am Heart J 2000; 140: 324–8.
  • Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Mark-ers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000; 343: 1139–47.
  • Morrow DA, Rifai N, Antman AN, Weiner DL, McCabe CH, Cannon CP, Braunwald E. C-reactive protein is a potent predictor of mortality independently or in combination with troponin T in acute coronary syndromes: a TIMI 11 A sub-study. J Am Coll Cardiol 1998; 31: 1460–5.
  • Ferreiros ER, Boissonnet CP, Pizarro R, Merletti PF, Corrado G, Cagide A, Bazzino 0. Independent prognostic value of elevated C-reactive protein in unstable angina. Cir-culation 1999; 100: 1958–63.
  • Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioi M, Lozniewski A, Loubinoux J, Le Faou A, Gueant JL. C-Reactive protein and coronary artery disease: Addi-tional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J1999; 137: 346-51.
  • Ilhan F, Akbulut H, Karaca I, Godekmerdan A, Ilkay E, Bulut V. Procalcitonin, C-reactive protein and neopterin levels in patients with coronary atherosclerosis. Acta Cardiol 2005; 60 (4): 361–5.
  • Remskar M, Horvat M, Hojker S, Noc M. Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochen-schr 2002; 114: 205–10.
  • Buratti T, Ricevuti G, Pechlaner C, Joannidis M, Wieder-mann FJ, Gritti D, Herold M, Wiedermann CJ. Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarc-tion. Inflammation 2001; 25: 97–100.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.